loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Ceftazidime

    Menu

    Ceftazidime

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 374Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 50578 / DOSAGE - INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CEFTAZIDIME SODIUM(UNII: CMC30V039K)
    (CEFTAZIDIME - UNII:9M416Z9QNR)     		CEFTAZIDIME SODIUM20mg in 1

    Inactive Ingredients

    Ingredient Name
    Covis Pharmaceuticals, Inc.
    Cardinal Health
    GlaxoSmithKline Manufacturing SpA
    DEXTROSE(IY9XDZ35W2)  
    HYDROCHLORIC ACID(QTT17582CB)  
    SODIUM CARBONATE(45P3261C7T)
    SODIUM HYDROXIDE(55X04QC32I)